Indian startup CrisprBits closed $3 million in pre-Series A funding led by Spectrum Impact to commercialize its PathCrisp CRISPR-based diagnostic platform and to accelerate development of CRISPR-driven strain engineering and gene-editing tools. The company plans to scale diagnostics manufacturing and expand into Africa and Latin America, while advancing an AI-augmented strain engineering platform for industrial sustainability use cases. PathCrisp offers rapid (sub-3-hour) results and targets human health, food safety and animal health markets. The raise underscores continued investor interest in decentralized, low-infrastructure molecular diagnostics and CRISPR-enabled industrial applications — particularly in emerging markets where affordability and ease-of-use drive adoption.